APA (7th ed.) Citation

M, P., E, B., C, M., T, R., I, G., L, A., . . . M, L. (2025). Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis. European journal of clinical investigation, 55(6), e70001. https://doi.org/10.1111/eci.70001

Chicago Style (17th ed.) Citation

M, Perachino, et al. "Adverse Events and Impact on Quality of Life of Antibody-drug Conjugates in the Treatment of Metastatic Breast Cancer: A Systematic Review and Meta-analysis." European Journal of Clinical Investigation 55, no. 6 (2025): e70001. https://doi.org/10.1111/eci.70001.

MLA (9th ed.) Citation

M, Perachino, et al. "Adverse Events and Impact on Quality of Life of Antibody-drug Conjugates in the Treatment of Metastatic Breast Cancer: A Systematic Review and Meta-analysis." European Journal of Clinical Investigation, vol. 55, no. 6, 2025, p. e70001, https://doi.org/10.1111/eci.70001.